Breast biopsy procedures caused by false-positive diagnostic assessments in the US cost the healthcare system more than $2 billion per year. Imagio® could mitigate that by providing real-time information regarding suspicious breast masses and increased decision confidence regarding the need for invasive breast biopsies and additional exams.
The i-STAT Alinity TBI Plasma Test is the first rapid, handheld blood test for concussions that uses brain-specific biomarkers to help physicians objectively evaluate the need for a head CT scan. Unnecessary CT scans for mild traumatic brain injuries may be reduced by up to 40%, which minimizes radiation exposure and shortens hospital wait times.
The Portable Edge AI-DR is the world’s first AI-assisted system to be integrated into a handheld fundus camera to detect diabetic retinopathy (DR). The system can accurately identify four main DR lesions and classify five severity levels, assisting physicians in early diagnosis of DR. This will benefit people who need diabetes care in remote areas.